AMD Achieves First TSMC N2 Product Silicon Milestone

— Next-generation AMD EPYC CPU, codenamed "Venice," is the first HPC product to be brought up on TSMC's next-generation N2 node —

AMD (NASDAQ: AMD) today announced its next-generation AMD EPYC™ processor, codenamed "Venice," is the first HPC product in the industry to be taped out and brought up on the TSMC advanced 2nm (N2) process technology. This highlights the strength of AMD and TSMC semiconductor manufacturing partnership to co-optimize new design architectures with leading-edge process technology. It also marks a major step forward in the execution of the AMD data center CPU roadmap, with "Venice" on track to launch next year. AMD also announced the successful bring up and validation of its 5 th Gen AMD EPYC™ CPU products at TSMC's new fabrication facility in Arizona, underscoring its commitment to U.S. manufacturing.

"TSMC has been a key partner for many years and our deep collaboration with their R&D and manufacturing teams has enabled AMD to consistently deliver leadership products that push the limits of high-performance computing," said Dr. Lisa Su, chair and CEO, AMD. "Being a lead HPC customer for TSMC's N2 process and for TSMC Arizona Fab 21 are great examples of how we are working closely together to drive innovation and deliver the advanced technologies that will power the future of computing."

"We are proud to have AMD be a lead HPC customer for our advanced 2nm (N2) process technology and TSMC Arizona fab," said TSMC Chairman and CEO Dr. C.C. Wei. "By working together, we are driving significant technology scaling resulting in better performance, power efficiency and yields for high-performance silicon. We look forward to continuing to work closely with AMD to enable the next era of computing."

Supporting Resources

  • Learn more about AMD EPYC Processors

About AMD
For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies. Billions of people, leading Fortune 500 businesses and cutting-edge scientific research institutions around the world rely on AMD technology daily to improve how they live, work and play. AMD employees are focused on building leadership high-performance and adaptive products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website , blog , LinkedIn and X pages.

Cautionary Statement
This press release contains forward-looking statements concerning Advanced Micro Devices, Inc. (AMD) such as AMD's partnership with TSMC; next-generation AMD EPYC™ processors to be taped out and brought up on the TSMC advanced 2nm process technology and being on track to launch next year; AMD's data center CPU roadmap; and 5th Gen AMD EPYC™ CPU products being planned for shipment later this year, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "expects," "believes," "plans," "intends," "projects" and other terms with similar meaning. Investors are cautioned that the forward-looking statements in this press release are based on current beliefs, assumptions and expectations, speak only as of the date of this press release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. Such statements are subject to certain known and unknown risks and uncertainties, many of which are difficult to predict and generally beyond AMD's control, that could cause actual results and other future events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Material factors that could cause actual results to differ materially from current expectations include, without limitation, the following: Intel Corporation's dominance of the microprocessor market and its aggressive business practices; Nvidia's dominance in the graphics processing unit market and its aggressive business practices; competitive markets in which AMD's products are sold; the cyclical nature of the semiconductor industry; market conditions of the industries in which AMD products are sold; AMD's ability to introduce products on a timely basis with expected features and performance levels; loss of a significant customer; economic and market uncertainty; quarterly and seasonal sales patterns; AMD's ability to adequately protect its technology or other intellectual property; unfavorable currency exchange rate fluctuations; ability of third party manufacturers to manufacture AMD's products on a timely basis in sufficient quantities and using competitive technologies; availability of essential equipment, materials, substrates or manufacturing processes; ability to achieve expected manufacturing yields for AMD's products; AMD's ability to generate revenue from its semi-custom SoC products; potential security vulnerabilities; potential security incidents including IT outages, data loss, data breaches and cyberattacks; uncertainties involving the ordering and shipment of AMD's products; AMD's reliance on third-party intellectual property to design and introduce new products; AMD's reliance on third-party companies for design, manufacture and supply of motherboards, software, memory and other computer platform components; AMD's reliance on Microsoft and other software vendors' support to design and develop software to run on AMD's products; AMD's reliance on third-party distributors and add-in-board partners; impact of modification or interruption of AMD's internal business processes and information systems; compatibility of AMD's products with some or all industry-standard software and hardware; costs related to defective products; efficiency of AMD's supply chain; AMD's ability to rely on third party supply-chain logistics functions; AMD's ability to effectively control sales of its products on the gray market; long-term impact of climate change on AMD's business; impact of government actions and regulations such as export regulations, tariffs and trade protection measures; AMD's ability to realize its deferred tax assets; potential tax liabilities; current and future claims and litigation; impact of environmental laws, conflict minerals related provisions and other laws or regulations; evolving expectations from governments, investors, customers and other stakeholders regarding corporate responsibility matters; issues related to the responsible use of AI; restrictions imposed by agreements governing AMD's notes, the guarantees of Xilinx's notes and the revolving credit agreement; impact of acquisitions, joint ventures and/or strategic investments on AMD's business and AMD's ability to integrate acquired businesses, such as ZT Systems; impact of any impairment of the combined company's assets; political, legal and economic risks and natural disasters; future impairments of technology license purchases; AMD's ability to attract and retain qualified personnel; and AMD's stock price volatility. Investors are urged to review in detail the risks and uncertainties in AMD's Securities and Exchange Commission filings, including but not limited to AMD's most recent reports on Forms 10-K and 10-Q.

AMD, the AMD Arrow logo, EPYC and combinations thereof, are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ad5a4173-91fc-43cf-9833-8feeea9330e1


Contact: Aaron Grabein AMD Communications (737) 256-9518 aaron.grabein@AMD.com Liz Stine AMD Investor Relations +1 720-652-3965 liz.stine@AMD.com

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

AMD
The Conversation (0)
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical drug development company focused on developing a pipeline of proprietary small-molecule drug candidates for diseases with high unmet medical needs, today reports financial results for its first quarter of... Keep Reading...
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of Mr. John Bathery to its Board of Directors,... Keep Reading...
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer's disease pathology Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration Cash of $11.1M to support pharmaceutical developments into the fourth... Keep Reading...
InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today reports financial results for the second quarter of the fiscal year 2025... Keep Reading...
InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a significant safety marginDose ranging studies completed InMed Pharmaceuticals Inc. (NASDAQ:... Keep Reading...
Homerun Resources Inc. Closes $6M Financing with Institutional Investor Sorbie Bornholm LP

Homerun Resources Inc. Closes $6M Financing with Institutional Investor Sorbie Bornholm LP

Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) ("Homerun" or the "Company") is pleased to announce that it has closed its financing, previously announced on June 16, 2025, with an arm's length institutional investor, Sorbie Bornholm LP (the "Investor") for aggregate proceeds of... Keep Reading...
Hand pointing at glowing sun over rising stock chart, cityscape background.

Tech Weekly: S&P 500 Closes Near Record Ahead of Fed Interest Rate Decision

Welcome to the Investing News Network's weekly brief on tech news and tech stocks driving the markets. We also break down next week's catalysts to watch to help you prepare for the week ahead.Don't forget to follow us @INN_Technology for real-time news updates!Securities Disclosure: I, Meagen... Keep Reading...
Homerun Resources Inc. Announces Engagement of Jiri Skopek as Corporate Development Advisor for the Strategic Commercialization of the Enduring Long Duration Energy Storage System Integrated with "The Hub" AI Energy Management Platform

Homerun Resources Inc. Announces Engagement of Jiri Skopek as Corporate Development Advisor for the Strategic Commercialization of the Enduring Long Duration Energy Storage System Integrated with "The Hub" AI Energy Management Platform

Homerun Energy USA, Inc. ("Homerun" or the "Company") a newly formed 100% owned subsidiary of Homerun Resources, Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) is pleased to announce the engagement of Jiri Skopek as Corporate Development Advisor for the strategic development and commercialization of... Keep Reading...
Homerun Resources Inc. Executes NREL Enduring Thermal Energy Storage Global Intellectual Property Agreement Including New Patent Application and EMS Integration

Homerun Resources Inc. Executes NREL Enduring Thermal Energy Storage Global Intellectual Property Agreement Including New Patent Application and EMS Integration

KEY POINTSHomerun Energy USA, Inc. has executed a global Intellectual Property Agreement, or option agreement, with Alliance for Sustainable Energy LLC., the manager and operator of the U.S. Department of Energy's National Renewable Energy Laboratory (NREL) covering the intellectual property... Keep Reading...
Canadian flag graph with fluctuating stock market chart.

Will Canada’s 2025 Budget Boost Productivity? Experts Weigh In

Canada’s 2025 federal budget arrives at a pivotal moment for the country’s economic trajectory. Facing a decades-long productivity challenge, the government aims to reinvigorate growth through carefully targeted investment incentives and strategic reforms.Rather than broad fiscal stimulus, the... Keep Reading...
Homerun Resources Inc. Announces Listing of Its Shares on Tradegate Exchange in Germany Increasing European and International Market Liquidity

Homerun Resources Inc. Announces Listing of Its Shares on Tradegate Exchange in Germany Increasing European and International Market Liquidity

Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) ("Homerun" or the "Company") is pleased to announce that its common shares have commenced trading on the Tradegate Exchange in Germany, one of Europe's most liquid retail-focused trading platforms, significantly expanding the Company's... Keep Reading...

Latest Press Releases

Related News